Open link in next tab
FDA grants full approval to new Alzheimer's drug meant to slow disease
https://www.nbcnews.com/health/health-news/leqembi-alzheimers-drug-fda-approval-eisai-biogen-rcna92377
The first approved drug to slow the progression of the illness will come with a strong safety warning about potentially life-threatening side effects.
The first approved drug to slow the progression of the illness will come with a strong safety warning about potentially life-threatening side effects.